15 studies found for:    Open Studies | "Scleroderma, Localized"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Conditions: Scleroderma, Localized;   Morphea;   Frontal Linear Scleroderma en Coup de Sabre;   Scleroderma, Circumscribed;   Scleroderma, Linear
Intervention: Other: Morphea
2 Recruiting Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea
Conditions: Scleroderma, Localized;   Morphea;   Scleroderma, Circumscribed
Interventions: Procedure: UVA-1 Phototherapy;   Procedure: Placebo
3 Recruiting Molecular Effects of Topical Calcipotriene on Morphea
Conditions: Morphea;   Localized Scleroderma
Intervention: Drug: topical calcipotriene 0.005% ointment
4 Recruiting Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Condition: Localized Scleroderma
Interventions: Device: Fractional carbon dioxide laser;   Device: Ultraviolet A1 phototherapy (UVA1)
5 Recruiting Genetic Variants in Linear Localized Scleroderma
Condition: Morphea
Intervention: Other: skin biopsy
6 Recruiting Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers and Patients With Cutaneous Scleroderma
Conditions: Limited Scleroderma;   Localized Scleroderma;   Diffuse Scleroderma
Interventions: Drug: MRG-201;   Drug: Placebo
7 Not yet recruiting Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
Condition: Scleroderma
Interventions: Drug: Clobetasol;   Drug: Calcipotriene;   Drug: Tacrolimus
8 Recruiting Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement
Conditions: Scleroderma, Systemic;   Sleep Apnea, Obstructive;   Pulmonary Disease
Intervention: Other: No intervention
9 Not yet recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
10 Recruiting Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Conditions: SYSTEMIC SCLERODERMA;   ALLOGENEIC MESENCHYMAL STEM CELLS;   ADULT
Intervention: Biological: INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
11 Recruiting Calcinosis in a Single-Center Scleroderma Population
Conditions: Scleroderma;   Calcinosis
Intervention:
12 Recruiting Zibotentan Better Renal Scleroderma Outcome Study
Conditions: Scleroderma;   Scleroderma Renal Crisis;   Chronic Kidney Disease
Intervention: Drug: Zibotentan
13 Recruiting Scleroderma Registry & Repository at the Hospital for Special Surgery
Condition: Scleroderma
Intervention:
14 Unknown  Influenza Vaccination in Patients With Scleroderma
Condition: Influenza Vaccine in Scleroderma
Intervention: Biological: Influenza vaccine
15 Recruiting Microvascular and Fibrosis Imaging Study
Conditions: Autoimmune Diseases;   Sickle Cell Disease;   Chronic Graft Versus Host Disease
Interventions: Other: Acoustic Radiation Force Impulse (ARFI);   Other: Laser Doppler Flowmetry (LDF);   Other: Laser Doppler Perfusion Imaging (LDI);   Other: Optical Coherence Tomography (OCT);   Other: Orthogonal Polarization Spectral Imaging (OPSI);   Other: Nail fold video capillaroscopy (NVC)

Indicates status has not been verified in more than two years